skip to Main Content

Two Migration Proteins Boost Predictive Value of Pancreatic Cancer Biomarker

Newsfeed image, light gray text on dark gray background

Adding two blood-borne proteins associated with cancer cell migration increases the predictive ability of the current biomarker for pancreatic cancer to detect early stage disease, a research team from The University of Texas MD Anderson Cancer Center reports in the Journal of the National Cancer Institute.

The trio of biomarkers, tested in three separate cohorts, including two blinded validation studies, improved the detection of patients with early stage disease compared to healthy or benign disease controls. Read more . . .

Back To Top